Ruoxi Hu

Mass Medical Angels LLC (MA2) is an angel firm founded in 2009 by Richard Anders and Roger Kitterman. The firm is headquartered in Boston, Massachusetts.

Starlight Cardiovascular, Inc. is a medical device company based in San Diego, CA. Starlight Cardiovascular, Inc. develops tools and devices to treat pediatric congenital heart defects. The company was founded by Beverly Tang, Pedro del Nido, Carl M. Berke, Attila Meretei, Tom Duerig, and Beverly Tang has been the CEO since incorporation.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA.

CodaMetrix, Inc. develops an AI-platform that translates clinical information into accurate sets of medical codes for patient care and revenue cycle processes. The company is based in Boston, MA. The company was founded in 2019. The CEO is Hamid Tabatabaie.

Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA.

InStride Health, Inc. provides evidence-based anxiety and OCD treatment for children and young adults aged 7 to 22. InStride Health is based in Wellesley, MA and was founded by Mona Potter, Kathryn Boger, James McElhiney, and John Voith. The company aims to engage kids and teens every step of the way and offers resources and information for media to learn how they help their patients connect and thrive. John Voith has been the CEO since incorporation.

Sequre Dx, Inc. is a genomics intelligence company that focuses on advancing on-target gene editing and cell therapies from discovery to patient. The company is based in Waltham, MA. The company offers preclinical platforms for the biopharma industry, including diagnostic assays and bioinformatic analytics that solve preclinical off-target evaluation needs. Sequre Dx aims to make gene editing and cell therapies suitable for all patients who would benefit from these life-saving technologies. The CEO of the company is Ellen E. Sheets.

Angel Healthcare Investors LLC provides financing for businesses. It is a private equity and venture capital firm specializing in early stage ventures, turnarounds, and spin-offs. The firm typically invests in companies with a direct healthcare and life sciences application, biotechnology, bioinformatics, medical device, medical testing, analysing and diagnostic equipment and but may also consider other opportunities outside the healthcare industry. The company was founded by Alan Solomont, Susan Bailis and Dick Thielen on October 1, 1999 and is headquartered in Newton, MA.

InfoBionic, Inc. provides wireless remote patient monitoring systems. It specializes in cardiac arrhythmia detection and analytics monitoring. The company was founded by Nancy M. Briefs, Michael Fahey, Ravi Kuppuraj and Jeremy N. Ruskin in 2011 and is headquartered in Lowell, MA.

Kasalis, Inc. supplies advanced manufacturing systems for optoelectronics devices. Its products include camera assembly systems, selection guide, and services and support. The company was founded in 2011 and is headquartered in Burlington, MA.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA.

X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA.

Partners Innovation Fund II LP invests in companies located in the United States. The fund targets companies operating in the fields of life sciences includes drugs, devices, diagnostics, and digital health. It provides financing for seed and early stage capital requirements. It makes co-investments.

SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Partners Innovation Fund LLC, an Evergreen Fund, invests in companies located in the US. The fund targets companies operating in the fields of healthcare sector. It provides financing for seed and early stage capital requirements. It also makes follow on investments.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA.

Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.

Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India.

Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts.

Bracebridge Capital LLC (Bracebridge) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1994 by Nancy Zimmerman and Gabriel Sunshine. They are owned by Bracebridge Capital II LP. Bracebridge provides investment advisory services to pooled investment vehicles.

Violet Therapeutics is an American healthcare company founded by Meredith Fisher. Meredith Fisher has been the CEO since incorporation.

Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation.

Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA.

Founded in 2015, DalCor Pharma UK Ltd. is a subsidiary of DalCor Pharmaceuticals Canada, Inc. The company is based in Leatherhead, UK. The British company engages in research and experimental development on biotechnology.

Boston Biomedical Innovation Center operates a life sciences accelerator that aims to accelerate innovation and translational research in healthcare.

Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA.